Aurobindo Pharma announced that Natrol LLC, USA, a wholly owned step-down subsidiary of the Company, has entered into a definite agreement with New Mountain Capital LLC, NY and its affiliate Jarrow Formulas
Inc., to dispose of its business assets as a going concern with related assets, liabilities, products, brands and employees for a cash consideration of USD 550 million. The transaction is expected to close by January 2021.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
